Researchers identified 26,168 metastatic prostate cancer patients from a national database who were diagnosed between 2000 and 2016. Of those, 16,732 died during follow-up.
While the majority of deaths (77.8 percent) were from prostate cancer, 16.7 percent were from non-cancer causes such as cardiovascular diseases, chronic obstructive pulmonary diseases and cerebrovascular diseases, findings showed. About 6 percent of deaths were attributed to other cancers.
Overall, non-prostate cancer-related causes of death accounted for a greater percentage of deaths among patients ages 50 and older compared to younger patients.
“These findings suggest that therapy and follow-up should be tailored to the needs of each patient with metastatic [prostate cancer] and that counseling should be provided regarding future health risks,” researchers said.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
